{"title":"Discriminative Accuracy of the Simplified Spirometry for Identifying Spirometry-defined Chronic Obstructive Pulmonary Disease in Community.","authors":"Fan Wu,Gaoying Tang,Zhishan Deng,Qi Wan,Kunning Zhou,Heshen Tian,Binwei Hao,Cuiqiong Dai,Zihui Wang,Siqi Zou,Xiulin Liao,Si Huang,Qiaorui Zhou,Yuyan Hou,Jincong Gan,Huixian Lin,Xianliang Zeng,Lifei Lu,Suyin Huang,Changli Yang,Shengtang Chen,Yongqing Huang,Shuqing Yu,Yumin Zhou,Pixin Ran","doi":"10.1016/j.chest.2025.04.041","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nLow spirometry testing rate for screening of chronic obstructive pulmonary disease (COPD) is partly attributed to complex procedures, stringent quality control requirements, and long examination times. Simplifying the spirometry protocol may increase the feasibility of COPD screening in community settings.\r\n\r\nRESEARCH QUESTION\r\nDoes the simplified spirometry protocol have high diagnostic accuracy and time efficiency in screening for COPD?\r\n\r\nSTUDY DESIGN AND METHODS\r\nWe designed a community-based, cross-sectional diagnostic study. Participants completed spirometry tests using both simplified and routine protocols. Routine spirometry was defined by three maneuvers meeting acceptability and reproducibility criteria according to international standards, while simplified spirometry required only the first acceptable maneuver. The primary outcome was the diagnostic accuracy of prebronchodilator simplified spirometry for identifying spirometric COPD (post-bronchodilator forced expiratory volume in 1 second/forced vital capacity<0.70) measured by the area under the receiver operating characteristic curve (AUC). Secondary outcomes included positive predictive value (PPV), negative predictive value (NPV), sensitivity, specificity, examination time, and consistency of spirometry indicators between the two protocols.\r\n\r\nRESULTS\r\nOut of 632 screened participants, 619 were analyzed. The prebronchodilator simplified spirometry demonstrated high diagnostic accuracy (AUC: 0.972 [95%CI: 0.955-0.983]), with a PPV of 77.4% (95% CI: 72.3-82.5), NPV of 98.1% (95% CI: 96.6-99.5), sensitivity of 96.6% (95%CI: 94.1-99.1%) and specificity of 86.0% (95%CI: 82.6-89.3%) for identifying spirometric COPD. The average examination time was significantly shorter with prebronchodilator simplified spirometry compared with postbronchodilator routine spirometry (2.8±2.2 minutes vs. 32.1±5.4 minutes; difference: 29.3 minutes [95%CI: 28.9-29.7]). A high consistency was observed between the spirometry indicators obtained from the simplified and routine protocols.\r\n\r\nINTERPRETATION\r\nPrebronchodilator simplified spirometry demonstrates high diagnostic accuracy, sensitivity, and specificity for spirometric COPD screening in community settings. It significantly reduces examination time compared with routine spirometry, offering a feasible alternative for large-scale COPD screening initiatives.","PeriodicalId":9782,"journal":{"name":"Chest","volume":"8 1","pages":""},"PeriodicalIF":9.5000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chest","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.chest.2025.04.041","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Low spirometry testing rate for screening of chronic obstructive pulmonary disease (COPD) is partly attributed to complex procedures, stringent quality control requirements, and long examination times. Simplifying the spirometry protocol may increase the feasibility of COPD screening in community settings.
RESEARCH QUESTION
Does the simplified spirometry protocol have high diagnostic accuracy and time efficiency in screening for COPD?
STUDY DESIGN AND METHODS
We designed a community-based, cross-sectional diagnostic study. Participants completed spirometry tests using both simplified and routine protocols. Routine spirometry was defined by three maneuvers meeting acceptability and reproducibility criteria according to international standards, while simplified spirometry required only the first acceptable maneuver. The primary outcome was the diagnostic accuracy of prebronchodilator simplified spirometry for identifying spirometric COPD (post-bronchodilator forced expiratory volume in 1 second/forced vital capacity<0.70) measured by the area under the receiver operating characteristic curve (AUC). Secondary outcomes included positive predictive value (PPV), negative predictive value (NPV), sensitivity, specificity, examination time, and consistency of spirometry indicators between the two protocols.
RESULTS
Out of 632 screened participants, 619 were analyzed. The prebronchodilator simplified spirometry demonstrated high diagnostic accuracy (AUC: 0.972 [95%CI: 0.955-0.983]), with a PPV of 77.4% (95% CI: 72.3-82.5), NPV of 98.1% (95% CI: 96.6-99.5), sensitivity of 96.6% (95%CI: 94.1-99.1%) and specificity of 86.0% (95%CI: 82.6-89.3%) for identifying spirometric COPD. The average examination time was significantly shorter with prebronchodilator simplified spirometry compared with postbronchodilator routine spirometry (2.8±2.2 minutes vs. 32.1±5.4 minutes; difference: 29.3 minutes [95%CI: 28.9-29.7]). A high consistency was observed between the spirometry indicators obtained from the simplified and routine protocols.
INTERPRETATION
Prebronchodilator simplified spirometry demonstrates high diagnostic accuracy, sensitivity, and specificity for spirometric COPD screening in community settings. It significantly reduces examination time compared with routine spirometry, offering a feasible alternative for large-scale COPD screening initiatives.
期刊介绍:
At CHEST, our mission is to revolutionize patient care through the collaboration of multidisciplinary clinicians in the fields of pulmonary, critical care, and sleep medicine. We achieve this by publishing cutting-edge clinical research that addresses current challenges and brings forth future advancements. To enhance understanding in a rapidly evolving field, CHEST also features review articles, commentaries, and facilitates discussions on emerging controversies. We place great emphasis on scientific rigor, employing a rigorous peer review process, and ensuring all accepted content is published online within two weeks.